ID | 65705 |
フルテキストURL | |
著者 |
Sugimoto, Seiichiro
Department of General Thoracic Surgery and Organ Transplant Center, Okayama University Hospital
ORCID
Kaken ID
publons
researchmap
Matsubara, Kei
Department of General Thoracic Surgery and Organ Transplant Center, Okayama University Hospital
Tanaka, Shin
Department of General Thoracic Surgery and Organ Transplant Center, Okayama University Hospital
Miyoshi, Kentaroh
Department of General Thoracic Surgery and Organ Transplant Center, Okayama University Hospital
Kaken ID
Ishihara, Megumi
Department of General Thoracic Surgery and Organ Transplant Center, Okayama University Hospital
Toyooka, Shinichi
Department of General Thoracic Surgery and Organ Transplant Center, Okayama University Hospital
ORCID
Kaken ID
publons
researchmap
|
抄録 | The long-term survival after lung transplantation (LT) is favorable in Japan. However, longterm survivors after LT are subject to late complications, including chronic lung allograft dysfunction (CLAD), malignancy, infection, and chronic kidney disease (CKD) because of the need for lifelong immunosuppression. The rates of single cadaveric LT (CLT) and living-donor lobar LT (LDLLT) are higher than that of bilateral CLT in Japan. Here, we will describe the management of late complications and long-term outcome after LT in Japan. Attention should be paid to not only the phenotype of CLAD but also the difference in CLAD after CLT and after LDLLT as well as the timing of lung re-transplantation for advanced CLAD, especially after single CLT. Since post-transplant lymphoproliferative disorder is the most common malignancy after LT, infection monitoring for infection-related malignancies and appropriate screening are keys to the early diagnosis and treatment of malignancy after LT. The long-term management of infection after LT is also important, especially with regard to community-acquired pathogens, Aspergillus, and cytomegalovirus. When providing long-term care after LT, physicians should be aware of CKD and the timing of renal replacement therapy in cases with severe CKD. The widespread use of computed tomography and dialysis in Japan are beneficial for long-term survivors of LT. The similar survival outcomes of single CLT and LDLLT, compared with bilateral CLT, might contribute to improved long-term survival in Japan. Pulmonologists are encouraged to become further involved in long-term management after LT in Japan.
|
キーワード | Lung transplantation
chronic lung allograft dysfunction
infection
malignan
cychronic kidney
disease
|
発行日 | 2023-06-27
|
出版物タイトル |
Journal of Thoracic Disease
|
巻 | 15巻
|
号 | 9号
|
出版者 | AME Publishing Company
|
開始ページ | 5182
|
終了ページ | 5194
|
ISSN | 2072-1439
|
資料タイプ |
学術雑誌論文
|
言語 |
英語
|
OAI-PMH Set |
岡山大学
|
著作権者 | © Journal of Thoracic Disease.
|
論文のバージョン | publisher
|
PubMed ID | |
DOI | |
Web of Science KeyUT | |
関連URL | isVersionOf https://doi.org/10.21037/jtd-22-1679
|
ライセンス | https://creativecommons.org/licenses/by-nc-nd/4.0/
|
Citation | Sugimoto S, Matsubara K, Tanaka S, Miyoshi K, Ishihara M, Toyooka S. Long-term management and outcome of lung transplantation in Japan. J Thorac Dis 2023;15(9):5182-5194. doi: 10.21037/jtd-22-1679
|